As per a study by the International Osteoporosis Foundation (IOF), around 8.9 million people suffer from fractures every year. The main reason for fractures is the prevalence of osteoporosis. This will further lead to an increasing demand for kyphoplasty procedures, thus driving the Global Kyphoplasty Market. The information is shared by Fortune Business Insights in a report, titled “Kyphoplasty Market Size, Share and Global Trend By Product (Balloon, Cement Mixing, Needle, Others), By Application (Kyphosis, Spinal Fractures, Vertebral Alignment Restoration), By End User (Hospitals, Ambulatory Surgical Centers, Clinics) and Geography Forecast till 2026.” Osteoporosis is more prevalent in women than men.
Key questions answered in the Kyphoplasty Market report:
What will the market growth rate of Kyphoplasty market in 2026?
What are the key factors driving the Global Kyphoplasty market?
What are sales, revenue, and price analysis of top manufacturers of Kyphoplasty market?
Who are the distributors, traders and dealers of Kyphoplasty market?
Who are the key vendors in Kyphoplasty market space?
What are the Kyphoplasty market opportunities and threats faced by the vendors in the Asia Kyphoplasty market?
What are sales, revenue, and price analysis by types, application and regions of Kyphoplasty market?
What are the market opportunities, market risk and market overview of the Kyphoplasty market?
Medtronic Receives FDA Approval for its Second Cement Solution to Treat Sacral Fractures
The report profiles some of the leading players in the global kyphoplasty market. Some of them are Medtronic, Stryker, Merit Medical Systems, DePuy Synthes (Johnson & Johnson Services Inc.), Alphatec Spine Inc., G21 Srl, Taeyeon Medical Co. Ltd., Joline GmbH & Co. KG, iMEDICOM, and RONTIS. These companies have an expansive orthopaedic portfolio and robust distribution network. This allows them to sell their products effectively, which in turn, affects the kyphoplasty market revenue. SAFE ORTHOPEDICS announced the launch of a new kyphoplasty system called The SteriSpine VA in October 2018. This system holds a new cement injection method, which uses balloon for the treatment of fractures. In June 2018, Medtronic announced its second bone cement solution. This solution is for fixing pathological fractures of sacral vertebral body with the help of sacroplasty. The company received FDA approval for this solution called Kyphos(TM) Xpede Bone Cement.
More Trending Topics From Fortune Business [email protected]
Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.